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Pluripotency can be induced in differentiated murine
and human cells by retroviral transduction of Oct4,
Sox2, Klf4, and c-Myc. We have devised a reprog-
ramming strategy in which these four transcription
factors are expressed from doxycycline (dox)-induc-
ible lentiviral vectors. Using these inducible con-
structs, we derived induced pluripotent stem (iPS)
cells from mouse embryonic fibroblasts (MEFs) and
found that transgene silencing is a prerequisite for
normal cell differentiation. We have analyzed the tim-
ing of known pluripotency marker activation during
mouse iPS cell derivation and observed that alkaline
phosphatase (AP) was activated first, followed by
stage-specific embryonic antigen 1 (SSEA1). Expres-
sion of Nanog and the endogenous Oct4 gene, mark-
ing fully reprogrammed cells, was only observed late
in the process. Importantly, the virally transduced
cDNAs needed to be expressed for at least 12 days
in order to generate iPS cells. Our results are a step
toward understanding some of the molecular events
governing epigenetic reprogramming.
INTRODUCTION
The generation of pluripotent cell lines from somatic cells has
great potential for basic research as well as clinical applications
(Hochedlinger and Jaenisch, 2003; Rideout et al., 2002). Even
though epigenetic reprogramming of a somatic genome to an
embryonic state by nuclear transfer or fusion of ES cells with so-
matic cells has become a widely used procedure in various
mammalian species over the last decade (Cowan et al., 2005;
Kato et al., 1998; Polejaeva et al., 2000; Tada et al., 2001; Wa-
kayama et al., 1998; Wilmut et al., 1997), the underlying molecu-
lar mechanism has not been identified.
It has been shown recently that retroviral transduction of
mouse and human somatic cells with four transcription factors
initiates the gradual conversion of a small subpopulation of the
infected cells into a pluripotent, ES cell-like state (Maherali
et al., 2007; Meissner et al., 2007; Okita et al., 2007; Takahashi
et al., 2007; Takahashi and Yamanaka, 2006; Wernig et al.,
2007; Yu et al., 2007). In initial studies, mouse fibroblastsinfected with murine Moloney leukemia virus (MLV)-derived vec-
tors carrying the cDNAs of Oct4, Sox2, c-Myc, andKlf4 under the
control of the viral long terminal repeat (LTR) region gave rise to
ES cell-like iPS cells that were able to differentiate into cell types
of all three germ layers and contributed to the germline of chime-
ric mice (Maherali et al., 2007; Okita et al., 2007; Wernig et al.,
2007). More recently, iPS cells were isolated in the absence of
a transduced c-Myc gene, although with a significantly lower ef-
ficiency (Nakagawa et al., 2008; Wernig et al., 2008; Yu et al.,
2007). DNA methylation and histone modification analyses re-
vealed that the chromatin of mouse iPS cells had been reprog-
rammed to an embryonic state. This included demethylation of
the endogenous promoters controlling the ES cell-specific
genes Nanog and Oct4 and the simultaneous establishment of
both H3K4 and H3K27 trimethylation marks at loci previously
identified to be ‘‘bivalent’’ in ES cells (Bernstein et al., 2006; Ma-
herali et al., 2007; Okita et al., 2007; Wernig et al., 2007). During
the derivation process, iPS cells efficiently downregulated the
transcriptional activity of the viral LTRs to basal levels, suggest-
ing that viral transgene expression becomes dispensable at
a certain time point during the reprogramming process. Though
the isolation of human iPS cells has been achieved recently
(Takahashi et al., 2007; Yu et al., 2007), the translation of this
approach for clinical use faces a number of problems. Onemajor
obstacle is the stochastic reactivation of the viral transgenes,
which has been linked to an elevated frequency of tumor forma-
tion in iPS cell-derived chimeric mice (Okita et al., 2007).
In previous studies, iPS cell colonies were detected at widely
differing time points after infection of somatic cells. Depending
on the selection strategy employed, cells undergoing reprog-
ramming could be enriched for by drug selection starting as early
as on day 3 and as late as several weeks after infection (Maherali
et al., 2007; Okita et al., 2007; Wernig et al., 2007). Our recently
published data demonstrated that cells originating from the
same infected parental cell activate the endogenous Oct4 locus
at different time points, suggesting that the induction of pluripo-
tency by viral transduction is a gradual process involving sto-
chastic epigenetic events (Meissner et al., 2007). Viral trans-
duction-mediated reprogramming involves the transcriptional
activation of endogenous markers for pluripotency such as AP,
SSEA1, Sox2, Oct4, and Nanog (Maherali et al., 2007; Meissner
et al., 2007; Okita et al., 2007; Wernig et al., 2007). It is unclear,
however, whether the reactivation of pluripotency-associated
genes is a random, stochastic process or follows a specific set
of sequential events, and the minimal length of transgene
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determined. Understanding the timing of endogenous gene acti-
vation and transgene silencing is fundamental for the develop-
ment of transient, nonviral reprogramming strategies.
In order to study the activation of endogenous genes during
the reprogramming process and the time requirements for ec-
topic expression of the four factors, we have developed a lentivi-
ral system in which the cDNAs of the four transcription factors
are driven from a dox-inducible promoter. In contrast to previ-
ously employed retroviral systems (Maherali et al., 2007; Meiss-
ner et al., 2007; Okita et al., 2007; Wernig et al., 2007), this allows
for controlled expression of all four transgenes independent of
viral integration and cellular silencing of viral LTRs. We have de-
rived iPS cell lines after infection of fibroblasts obtained from
Oct4-GFP mice or Nanog-GFP mice expressing the M2rtTA
from the endogenous Rosa26 (R26) promoter. By utilizing induc-
ible viruses, we were able to activate or downregulate the ex-
pression of the four factors at different time points and to analyze
the timing of the reprogramming process. Using FACS analysis,
we assessed the activation of the four ES cell markers AP,
SSEA1, Oct4-GFP, and Nanog-GFP and found that SSEA1
expression marks an intermediate state of reprogramming,
whereas Oct4 and Nanog expression was only detected in fully
reprogrammed cells. We also identified theminimum time of viral
transgene expression required for completion of the reprogram-
ming process and determined the effect of continued expression
of the four factors on the differentiation potential of several iPS
cell lines.
RESULTS
A Dox-Inducible System for the Derivation
of Pluripotent Cell Lines
A lentiviral backbone for dox-inducible transgene expression
was constructed by replacing the human ubiquitin C promoter
of the FUWplasmid (Lois et al., 2002) with a tetracycline operator
and minimal CMV promoter. The cDNAs for Oct4, Sox2, Klf4,
and c-Myc were subsequently cloned into this backbone. We
generated mouse embryonic fibroblasts (MEFs) carrying the
R26 promoter-drivenM2rtTA (Beard et al., 2006) and aGFP allele
driven by either the endogenous Oct4 or Nanog promoter (Ma-
herali et al., 2007; Meissner et al., 2007).M2rtTA+/;Oct4GFP+/
andM2rtTA+/;NanogGFP+/MEFs were infected with inducible
Oct4, Sox2, c-Myc, and Klf4 viruses and subsequently treated
with dox (Figure 1A). To determine the expression levels of the
four genes from the inducible viruses, we performed quantitative
PCR analysis showing that ectopic transcript expression could
be strongly induced in the presence of dox (see Figure S1 avail-
able online).
To generate iPS cell lines, 2.5 3 105 MEFs were infected in
10 cm cell culture dishes. The cultures were split 1:5 at 3 days
after infection. Dox was added to the cell culture medium 1 day
following the split to induce transgene expression and initiate the
reprogramming process. In the presence of dox, themorphology
of the infected MEFs changed within 3 days, with small, rounded
cells forming in the culture. Similar to previous observations (Ma-
herali et al., 2007;Meissner et al., 2007; Okita et al., 2007;Wernig
et al., 2007), small colonies were observed by day 9 and ES-
like colonies appeared by day 16, many of which had activated
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pression. ES-like colonies were not observed in cultures that had
not been treated with dox. We picked single GFP-positive colo-
nies from the dox-treated plates at day 26 and expanded them
on feeder MEFs in the absence of dox to derive iPS cell lines
(Figure 1B). Viable chimeras were generated from both Oct4-
GFPandNanog-GFP iPS clones after injection intoBALB/Cblas-
tocysts (Figures 1C and 1D).
Sequential Activation of Pluripotency Markers
In order to provide a baseline measure of endogenous ES cell
marker activation during the direct reprogramming of MEFs,
we performed FACS analyses of AP, SSEA1, and Oct4- or
Nanog-driven GFP. For each experiment, Oct4-GFP and
Nanog-GFP cells were infected with the same batch of virus to
reduce variability. Three days after infection, the MEFs were split
onto gelatin-coated 10 cm plates. The next day, dox was added
to all plates (day 0). The expression of ES cell-specific markers
was analyzed at various time points after dox addition up to
day 35. The average percentages of cells expressing AP,
SSEA1, Oct4-GFP, or Nanog-GFP from three independent ex-
periments are displayed in Figure 2. Representative FACS plots
for AP and SSEA1/Oct4-GFP or SSEA1/Nanog-GFP analysis are
displayed in Figure S2. Since the GFP signal to background fluo-
rescence ratio was low, we performed autofluorescence correc-
tion as outlined elsewhere (Alberti et al., 1987). Consistent with
our previous observations (Wernig et al., 2007), AP was reacti-
vated early after induction of the four factors and was detectable
in a small percentage (3%–4%) of cells at day 3. SSEA1 was
first expressed in a subpopulation of cells (4%) at day 9 and
GFP expression from either the Oct4 or Nanog endogenous
promoters was first observed by FACS at day 16, with the per-
centage of GFP-positive cells being below 1% in both cases.
We performed quantitative RT-PCR assays on whole-cell popu-
lations as well as on SSEA1-positive cells to investigate whether
transcriptional activation of the endogenous Nanog or Sox2 loci
was detectable before the appearance of GFP-positive cells. We
found no significant levels of either transcript at time points up to
day 9 of dox induction (Figure S3). The portion of cells expressing
AP, SSEA1, or GFP increased in both reporter lines over time,
consistent with our previous results (Wernig et al., 2007).
SSEA1 Activation Marks an Intermediate
Step of Reprogramming
The timing of marker appearance observed by FACS suggests
that the activation of AP, SSEA1, Oct4, and Nanog might be se-
quential events. This notion is supported by the observation that
at day 9 after infection only about 7% of the AP-positive cells
also expressed SSEA1 and at day 16 only about 3% of the cells
staining for SSEA1 also expressed Nanog or Oct4 as indicated
by GFP fluorescence. In contrast, most if not all GFP-positive
cells also expressed SSEA1. To test the hypothesis that
SSEA1 andOct4/Nanog are sequentially activated, we sorted in-
fected populations of Oct4-GFP and Nanog-GFP cells at day 21
of dox treatment (Figure 3A). Equal numbers of SSEA1+/GFP
cells were plated on feeders and cultured for 3 days either in
the presence or in the absence of dox. After 3 days, the medium
was changed and the cells were incubated in dox-free medium
for an additional 7 days. GFP-positive colonies were observed
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(A) Somatic cells harboring a GFP reporter driven by the endogenous Oct4 or Nanog promoters were infected with tet-inducible lentiviral vectors carrying the
cDNAs of Oct4, Sox2, Klf4, and c-Myc.
(B) The addition of dox after infection induced lentiviral expression and subsequently led to reprogrammed, GFP-positive iPS cell colonies.
(C and D) The iPS cells were pluripotent and contributed to viable chimeras after injection into BALB/C host blastocysts as indicated by coat color. White mice are
nonchimeric BALB/C animals, whereas mixed coat color mice are chimeric.in both treated and untreated cultures of SSEA1+/GFP cells
(Figure 3B). The percentage of SSEA1+/GFP cells that were
able to generate GFP-positive colonies was calculated. In both
the Oct4-GFP and the Nanog-GFP cell populations, 0.02% of
the SSEA1+/GFP cells gave rise to GFP-positive colonies with-
out dox treatment. This percentage increased about 10-fold to
0.2%when the cells were treated with dox, indicating that con-
tinuous expression of the transcription factors enhanced reprog-
ramming in SSEA1+/GFP cells (Figure 3C). We confirmed the
existence of SSEA1+/GFP+ cells in the sorted populations by
FACS analysis 11 days after the initial sort (Figure 3D). In contrast
to SSEA1+/GFP cells, SSEA1-/GFP cells did not give rise
to any GFP-positive colonies after 10 days of culturing with or
without dox.
To investigate whether the SSEA1+/GFP cells that did not
give rise to iPS cell colonies after dox withdrawal simply stopped
dividing while maintaining SSEA1 expression or returned to
a MEF-like SSEA1-negative state, we sorted cells after 9 days
of dox treatment—a time point well before the expres-
sion of Nanog-GFP or Oct4-GFP could be detected. TheSSEA1+/GFP cells were seeded onto plates with feeders and
cultured for 20 days with or without dox. In addition, some of
the SSEA1+/GFP cells were also seeded onto plates without
feeders to allow for the analysis of their morphology. At the
end of the culture period, we assessed SSEA1 and GFP expres-
sion by FACS analysis (Figure 4A). In contrast to the SSEA1+/
GFP populations sorted at day 21, the populations sorted at
day 9 did not give rise to any SSEA1+/GFP+ cells after culturing
them without dox, indicating the complete absence of trans-
gene-independent cells within the SSEA1+/GFP populations
sorted at this earlier time point. Furthermore, most if not all cells
cultured without dox ceased to express SSEA1 and returned to
a MEF-like morphology (Figure 4B). In contrast, when cultured in
the presence of dox, the SSEA1+/GFP cells from day 9 gave
rise to iPS colonies and yielded SSEA1+/GFP+ iPS cells at the
end of the culture period (Figures 4A and 4B).
Our results indicate that SSEA1 activation may represent an
intermediate step preceding the activation of Oct4 or Nanog.
The SSEA1-positive state seems to be instable, and SSEA1+/
GFP cells separated at day 9 depend on continued transgeneCell Stem Cell 2, 151–159, February 2008 ª2008 Elsevier Inc. 153
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Reactivation during Reprogramming
FACS analysis of AP, SSEA1, and GFP reactiva-
tion was performed on Nanog-GFP/M2rtTA and
Oct4-GFP/M2rtTA MEFs at different times after
the induction of reprogramming. Cells were har-
vested at various time points after the addition of
dox to the ES cell medium and incubated with an
APC-labeled anti-SSEA1 antibody and a fluores-
cent substrate that is activated in the presence
of AP activity. The data from three independent
experiments are summarized. Columns display
average percentages of cells expressing AP
(black), SSEA1 (white), and Nanog-GFP (diago-
nal), or Oct4-GFP (vertical). AP and SSEA1 values
represent averages of Nanog-GFP and Oct4-GFP
experiments. Error bars indicate standard devia-
tions.expression to complete the reprogramming process. When the
transgenes are turned off, the reprogramming process is halted
and the cells assume a state resembling that of the donor MEFs.
Our findings also indicate that reprogramming is a gradual, asyn-
chronous process and that continuous vector expression en-
hances reprogramming efficiency even at 21 days after the start
of dox induction, a time point well beyond the initial appearance
of GFP-positive iPS cells.
Minimal Time of Transgene Expression Required
for Direct Reprogramming
We investigated how long the exogenous expression of the four
factors was required for successful reprogramming of fibroblasts
to dox-independent, self-renewing iPS cells. For this, cells were
infected with the inducible lentiviruses and split onto six gelatin-
coated 10 cm plates 3 days later as outlined in Figure 5A. One
day after splitting the cells, doxwas added to the culturemedium
(day 0). The drug was withdrawn from individual cultures at var-
ious time points (days 12, 14, 16, 19, 22, and 26), and the dishes
were fixed and stained for AP on day 35 (Figure 5A). We found
that day 14 was the earliest time point of dox withdrawal that
was permissive to the establishment of dox-independent colo-
nies that stained positive for AP (Figure 5A). No dox-indepen-
dent, AP-positive colonies were observed on plates that had
dox withdrawn on day 12 (Figure 5A), even though AP-positive
cells were consistently detectable at the time of dox withdrawal
in our FACS experiments (compare Figure 2). These initial colo-
nies did not proliferate after dox withdrawal and did not stain
for AP at day 35. In the dishes in which dox was withdrawn at
later time points, the number of dox-independent, AP-positive
colonies increased with the time that the cells were exposed to
dox and therefore with the length of transgene expression
(Figure 5A).
To determine the time point of doxwithdrawal at which fully re-
programmed iPS cells could reproducibly be derived, we re-
peated this experiment in triplicate for both Nanog-GFP and
Oct4-GFP cells. This time we withdrew dox on days 9, 12, 14,
154 Cell Stem Cell 2, 151–159, February 2008 ª2008 Elsevier Inc.16, 21, and 24, respectively, and examined the plates for GFP-
expressing iPS colonies on day 35 (Figure 5B). Nomarked differ-
ences in colony counts were detected between Oct4-GFP and
Nanog-GFP cells, and the data obtained from both donor cell
lines were combined. We observed that dox-independent,
GFP-expressing iPS cell colonies could not reliably be detected
on plates that had dox removed on or prior to day 12, with four of
the six ‘‘day 12’’ plates containing no GFP-positive colonies, one
plate containing a single colony, and another plate containing
two GFP-positive colonies. Notably, a number of small colonies
were visible on these early withdrawal plates at the time of dox
removal (Figure S4A). However, these did not resemble ES cell
colonies and did not continue to proliferate once dox was with-
drawn (Figure S4B). Dox-independent, GFP-positive colonies
consistently appeared on plates treated with dox for 16 days
or longer, suggesting that some cells on those plates could pro-
liferate and self-renew independently of viral transgene expres-
sion. Consistent with our results from the AP stainings displayed
in Figure 5A, continued dox treatment increased the number of
transgene-independent and GFP-positive cells (Figure 5B). To-
gether, these results suggest that transgene expression is critical
for the formation of iPS cells at least up to days 12–16 and that
the continued expression of the transgenes beyond this time
point increases the number of iPS cell colonies. Shorter trans-
gene expression yields cells that are AP- and SSEA1-positive
but depend on transgene expression for progressing toward
a fully reprogrammed iPS cell state.
Differentiation of iPS Cells Requires Downregulation
of Transgene Expression
To test whether continuous transgene expression affected the
differentiation potential of the derived iPS lines, we compared
three iPS cell lines derived using inducible lentiviruses to iPS
cell lines obtained after transduction of MEFS with the four
cDNAs cloned into the constitutively expressed FUW lentiviral
vector (Lois et al., 2002). In this vector, the cDNAs are expressed
from the human ubiquitin C promoter that is ubiquitously
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(A) SSEA1+/GFP cells were sorted with an APC-conjugated SSEA1-antibody after 21 days of transgene expression and seeded on feeder MEFs.
(B) GFP-positive ES-like cell colonies were observed 10 days after sorting.
(C) Supplementation of the media with dox for an additional 3 days after sorting increased the percentage of SSEA1+/GFP cells that gave rise to GFP-positive
iPS cell colonies.
(D) Numbers from two independent experiments for Oct4-GFP and Nanog-GFP were averaged. Error bars indicate standard deviations. Confirmation of GFP-
positive cells in the sorted SSEA1+/GFP populations 11 days after initial sorting and seeding on feeder MEFs.expressed in mouse cells (Lois et al., 2002). We injected 53 105
cells of three iPS lines harboring inducible vectors (NS12, NS14,
and NS16) and of five lines harboring constitutive vectors subcu-
taneously into SCID mice. We used WT ES cells and ES cells
harboring the R26-M2rtTA allele as controls. Figure 6 shows rep-
resentative sections of ES cell- and iPS-derived tumors that were
stained for Oct4 expression. Whereas the tumors obtained from
the control ES cells and the inducible iPS cells displayed similar
states of differentiation, the tumors generated from iPS cell lines
harboring constitutively expressing vectors showed virtually no
differentiated cells. Most if not all cells in the FUW-derived iPS
cell tumors stained strongly for Oct4. This was in contrast to
the controls and the tumors obtained after injection of iPS cells
harboring inducible vectors where Oct4 was only expressed in
very few cells throughout the tumor. These results suggest that
continued ectopic expression of the four transcription factors
ablates the differentiation capacity of iPS cell lines.
DISCUSSION
In this study, we used an inducible, lentiviral system to generate
GFP-positive, pluripotent iPS cells from MEFs derived from
Oct4-GFP/R26-M2rtTA and Nanog-GFP/R26-M2rtTA mice. We
established iPS cell lines that were able to differentiate in tera-
toma assays and could produce viable chimeras. This is in con-
trast to iPS cells harboring constitutively expressing lentiviralconstructs that are not efficiently silenced in iPS cells. The in-
ducible system allowed us to investigate the timing and se-
quence of ES cell marker gene activation using FACS analysis.
We found direct in vitro reprogramming to be a gradual process
encompassing the sequential activation of four pluripotency
marker genes, with AP being expressed first on day 3 followed
by SSEA1 on day 9. GFP expressed from the endogenous pro-
moters of Oct4 or Nanog was first detectable on day 16 (Fig-
ure 7). SSEA1/GFP cells were not able to activate GFP
expression in the same time frame as SSEA1+/GFP cells,
and the progress from the SSEA1+/GFP state to the dox-inde-
pendent, fully reprogrammed SSEA1+/GFP+ state was greatly
enhanced by continued transgene expression. Together, these
results suggest that SSEA1+/GFP cells may represent a trans-
gene-dependent intermediate state of reprogramming. These
partially reprogrammed cells required continued transgene ex-
pression in order to progress toward a fully reprogrammed state,
whereas transgene downregulation caused reversion to a fibro-
blast-like, SSEA1-negative state. Finally, we demonstrated that
the generation of iPS cells requires the ectopic expression of
the four transcription factors for a minimum of 12–16 days (Fig-
ure 7). The removal of dox prior to or on day 12 resulted in the
return of colony-forming cells to a MEF-like state. The indepen-
dence from transgene expression closely correlated with the re-
activation of the endogenous Oct4 and Nanog loci (Figure 7). We
postulate that the activation of the endogenous Oct4 or Nanog
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dent iPS cells.
The sequential activation of pluripotency marker genes found
in this study is consistent with our previous observations from
MLV-based reprogramming strategies in which cells at day 14
after MLV infection expressed AP and SSEA1, but not Nanog,
whereas cells had activated all three markers at day 20 (Wernig
et al., 2007). Intriguingly, Nanog-neo MEFs in that study yielded
neomycin-resistant colonies even when the selection process
was initiated at day 6 after infection, a time point well before
Nanog expression could be detected by immunostaining (Wer-
nig et al., 2007). Similar results were reported in Okita et al.
(2007) and Maherali et al. (2007), where puromycin-resistant col-
onies were derived from Nanog-GFP-IRES-puro MEFs by start-
ing puromycin selection as early as 3 days after infection. This
discrepancy in timing between the appearance of antibiotic
resistance and protein detection could be due to a low level of
initial expression that is sufficient to render the partially reprog-
rammed cells drug resistant but below the level required to visu-
alize GFP and maintain pluripotency. This may be the result of
Figure 4. SSEA1+/GFP Cells Return to a MEF-like State upon Dox
Withdrawal
Oct4GFP/M2rTTA MEFs undergoing reprogramming were FACS sorted for
SSEA1 expression after 9 days of transgene expression (A). The cells were cul-
tured either in the presence or absence of dox for 20 days after the initial sort-
ing and then reanalyzed for SSEA1 and GFP expression. Plates that were
treated with dox contained SSEA1+/GFP+ and SSEA1+/GFP cells, whereas
cells on untreated plates had lost their SSEA1 expression (A). Culture in the
presence of dox yielded ES-like colonies, but in the absence of dox the
SSEA1+/GFP cells returned to a MEF-like morphology (B).
156 Cell Stem Cell 2, 151–159, February 2008 ª2008 Elsevier Inc.a gradual process of gene reactivation that occurs at different
times for specific markers, with AP and SSEA1 being activated
earlier than Oct4 or Nanog (Figure 7).
We found the time span at which transgene expression be-
comes dispensable for iPS cell derivation (12–16 days) to pre-
cede the appearance of GFP expression that marks the full
activation of the endogenous Oct4 and Nanog loci (day 16).
Since GFP detection by FACS requires a significant level of
protein expression, it is likely that this method overestimates
the minimum time span required for Nanog and Oct4 activation.
Delayed detection of GFP expression could also explain why
SSEA1+/GFP cells sorted at day 21, but not at day 9, contained
a small fraction of transgene-independent cells. These cells
might have activated the Oct4 or Nanog loci but did not as yet
display GFP expression levels high enough for FACS detection.
Sustained transgene expression beyond the minimal time re-
quirement increased the number of cells activating endogenous
Nanog and Oct4 expression, supporting the idea of stochastic
epigenetic events playing a role in four-factor reprogramming.
This is consistent with our previous observation that infected
cell populations continue to generate iPS colonies over
a drawn-out timewindow (Meissner et al., 2007). Our results sug-
gest that individual cells either enter the reprogramming process
at different time points after transgene induction or take different
times to go through the reprogramming sequence. Longer trans-
gene expression, therefore, would give more cells the chance to
undergo the required stochastic epigenetic changes and, conse-
quentially, proceed to a state of transgene independence.
In previous reports on iPS cell derivation from somatic cells,
transgene expression was driven by the LTRs of MLV-based
vectors, which were shown to be efficiently silenced in iPS cells
(Maherali et al., 2007; Okita et al., 2007; Wernig et al., 2007).
When we used constitutively expressed lentiviral vectors to gen-
erate iPS cell lines, we found these cells to be poorly capable to
differentiate in teratoma assays. This result supports the notion
that efficient transgene silencing is essential for the derivation
of truly pluripotent iPS cell lines. In a recent publication, iPS
cell lines generated using constitutive lentiviral vectors were re-
ported to differentiate in teratoma assays and to contribute to
various tissues of midgestation chimeric fetuses (Blelloch
et al., 2007). The cDNAs in that study were driven from the
CMV promoter, which has been shown to undergo methyla-
tion-mediated silencing in embryonic stem cells (Hong et al.,
2007; Xia et al., 2007), in contrast to the ubiquitin C promoter em-
ployed in our constitutively expressed viral constructs (Lois et al.,
2002). It is possible that the differentiation capabilities observed
in iPS cells harboring CMV-driven cDNAs could be a result of at
least partial silencing of the viral transgenes. Notably, no viable
chimeras have been reported from iPS cell lines derived using
constitutive lentiviral constructs so far (Blelloch et al., 2007).
Very recently, it has been reported that mouse and human iPS
cells can be generated without the use of a c-Myc transgene
(Nakagawa et al., 2008;Wernig et al., 2008; Yu et al., 2007). How-
ever, the forcedexpressionof c-Myc,aswell asother factors such
as Nanog and Lin28, has been found to have a substantial effect
on the efficiency and the timing of the reprogramming process.
While these reports are significant steps toward reducing the
tumorigenic potential of iPS cells and their derivatives, the final
solution to this problem will be the generation of transgene-free
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Expression for iPS Derivation
Infected MEFs were split into six dishes and cul-
tured in the presence of dox for a different number
of days as indicated by numbers next to the red
lines (A). Dox was withdrawn at different time
points as indicated by red bars, and the cells
were subsequently cultured in the absence of the
drug until day 35. All plates were stained for AP
at day 35 of reprogramming to determine how
many transgene-independent cells existed at the
time point of dox withdrawal. No AP-positive colo-
nies were observed when dox was withdrawn
before day 12, and the number of AP-positive col-
onies increased with the time the cells were ex-
posed to the drug (A). Similarly, infected MEFs
were grown in the presence of dox, and dox was
removed at different time points from the culture
medium. GFP-expressing iPS colonies were
counted on day 35. Data for Nanog-GFP and
Oct4-GFP experiments were averaged and the
number of colonies detected in six wells (three
for Oct4-GFP and three for Nanog-GFP cells) for
each time point is shown in the bar graph (B). Error
bars indicate standard deviation.iPS cells. The ability to quantify reprogramming dynamics in
a controlled system as presented here will be an invaluable tool
for the development of transient reprogramming strategies.
In conclusion, the results presented in this report clarify steps
involved in the generation of iPS cells by the expression of the
four transcription factors Oct4, Sox2, Klf4, and c-Myc. The infor-
mation on pluripotency marker activation and transgene expres-
sion provided here can be utilized as a benchmark for further
analyses of the reprogramming process and should allow for
the identification of factors that positively affect epigenetic re-programming. When compared to nuclear transfer, it is obvious
that reprogramming by viral transduction requires a longer pe-
riod of time, and it will be important to understand the molecular
basis for this difference. The determination of the minimum
length of transgene expression has implications for the develop-
ment of nonretroviral delivery methods of these four factors to
derive genetically unmodified iPS cells. Specifically, any tran-
sient expression strategy for iPS cell generation, such as protein
transduction, will need to provide protein expression at sufficient
levels for a minimum of 12–16 days. The generation of transient,Figure 6. Constitutive Expression of the
Four Factors Prevents Differentiation of
iPS Cells in Teratomas
Differentiation of iPS cells in teratomas was ab-
lated by continuous expression of transgenes in
iPS cells. Tumors derived from iPS cells express-
ing the four transgenes under the control of the
constitutive ubiquitin C promoter stained homoge-
neously positive for Oct4 and did not show normal
cell differentiation (A). IPS cells harboring the in-
ducible viral backbones differentiated readily after
downregulation of the transgenes in the absence
of dox (B). The tumors derived from these cells
were similar in size, fraction of cells staining posi-
tive for Oct4, and differentiation to tumors derived
from wild-type control ES cell lines (C) or ES cells
harboring the R26-M2rtTA allele (D).
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Kinetics of Direct Mouse Somatic Cell ReprogrammingFigure 7. Reprogramming of Somatic Cells: Sequential Marker Activation and Time of Virus Expression
The black arrow represents the time starting fromMLV vector infection (above, Maherali et al. [2007], Meissner et al. [2007], Okita et al. [2007], Wernig et al. [2007])
or dox induction (below) in days. For MLV infection, the earliest time points for two antibiotic selection strategies are indicated by blue bars, and the expression of
Nanog-GFP and Oct4-GFP is indicated by green bars. For dox-inducible transgenes, the minimum time of dox-induced transgene expression for successful iPS
cell derivation is displayed as a black bar. The expression timing of four pluripotency marker genes is indicated by red (AP and SSEA1) and green bars (Nanog-
GFP and Oct4-GFP).nonviral approaches in conjunction with a better understanding
of the reprogramming process will be an important step in the
development of stem cell-based therapies.
EXPERIMENTAL PROCEDURES
Reporter Cells
MEFs used in the infections with inducible lentiviruses were harvested at 13.5
dpc from F1matings between R26-M2rtTA mice (Beard et al., 2006) and either
Oct4-GFP (Meissner et al., 2007) or Nanog-GFP mice (Maherali et al., 2007).
MEFs used in the infections with constitutive lentiviruses were derived from
matings of mice carrying an Oct4-neomycin reporter allele (Wernig et al.,
2007) and expressed a p53 hairpin (Ventura et al., 2004).
Viral Constructs
To generate the tetracycline-inducible viral backbone, the human ubiquitin C
promoter and intronwere excised from FUW (Lois et al., 2002) by first digesting
with PacI, followed by 30 overhang removal with Klenow and subsequent di-
gest with BamHI. The tet operator/CMV promoter was excised from pRevTRE
(Clontech) by digesting first with BglII followed by fill-in followed by BamHI di-
gest. The TetO/CMV promoter and FUW backbone were then ligated. The
cDNAs for Oct4, Klf-4, Sox2, and c-Myc were subsequently cloned into the
EcoRI sites of the resulting vector. For the constitutive constructs, cDNAs
were cloned into the EcoRI site of FUW.
Cell Culture
Cells were cultured in standard ES cell culture conditions in DMEM supple-
mented with 10% FBS and LIF as described previously (Beard et al., 2006).
Infections
Virus was prepared as previously described. Briefly, 293T cells were trans-
fected with a mixture of viral plasmid and packaging constructs expressing
the viral packaging functions and the VSV-G protein. Medium was replaced
24 hr after transfection, and viral supernatants were collected at 48 and 72 hr.
After filtration, supernatants were pooled, and MEFs were incubated with
viral supernatants and fresh media at a ratio of 1:1 for 24 hr and subsequently
cultured in ES cell medium.
Blastocyst Injections
Injections of iPS cells into BALB/BALC host blastocysts were carried out as
previously described (Beard et al., 2006).
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For FACS analysis, we used an APC-conjugated anti-mouse SSEA1 (R&DSys-
tems,Minneapolis, MN) and an AP substrate kit, Vector Red substrate kit (Vec-
tor Laboratories, Burlingame, CA).
FACS
Cells were trypsinized, washed once in PBS, and resuspended in FACS buffer
(PBS + 5%CCS). 106 cells were stained with 10 ml of anti-SSEA1 antibody for
30 min, and for the stains that included the AP substrate, cells were then
washed once in PBS and fixed/permeabilized using an intracellular staining
kit (R&D Systems, Minneapolis, MN). After permeabilization, cells were treated
with 500 ml of AP substrate solution (Vector Laboratories, Burlingame, CA) for
20 min. Cells were then washed once with wash buffer and resuspended in
FACS buffer for analysis on a FACSCalibur cell sorter. For live sorting, cells
were stained with an APC-conjugated antibody against SSEA1 (R&D Systems,
Minneapolis, MN) and sorted on a FACSAria cell sorter.
Teratoma Assay
Cells were trypsinized, and 5 3 105 cells were injected subcutaneously into
SCID mice. After 14–21 days, teratomas were dissected, fixed in 10% phos-
phate-buffered formalin overnight, and subsequently embedded in paraffin
wax using a Tissue-Tek VIP embedding machine (Miles Scientific, Naperville,
IL) and a Thermo Shandon Histocenter 2 (Thermo Fisher Scientific, Waltham,
MA). Sections were cut at a thickness of 2 mm using a Leica RM2065 (Leica,
Wetzlar, Germany) and stained with hematoxylin and eosin or antibodies
against Oct4 as previously described (Hochedlinger et al., 2005).
Quantitative RT-PCR
Total RNAwas isolated using Trizol reagent (Invitrogen, Carlsbad, CA). Fivemi-
crograms of total RNA were treated with DNase I to remove potential contam-
ination of genomic DNA using a DNA Free RNA kit (Zymo Research, Orange,
CA). One microgram of DNase I-treated RNA was reverse transcribed using
a First-Strand Synthesis kit (Invitrogen) and ultimately resuspended in 100 ml
of water. Quantitative PCR analysis was performed in triplicate using 1/50 of
the reverse transcription reaction in an ABI Prism 7000 (Applied Biosystems,
Foster City, CA) with Platinum SYBR Green qPCR SuperMix-UDG with ROX
(Invitrogen). Primers used for amplification were as follows: Oct4 F, 50-ACAT
CGCCAATCAGCTTGG-30, and R, 50-AGAACCATACTCGAACCACATCC-30;
c-myc F, 50-CCACCAGCAGCGACTCTGA-30, and R, 50-TGCCTCTTCTCCACA
GACACC-30; Klf4 F, 50-GCACACCTGCGAACTCACAC-30, and R, 50-CCGTCC
CAGTCACAGTGGTAA-30; and Sox2 F, 50-ACAGATGCAACCGATGCACC-30,
and R, 50-TGGAGTTGTACTGCAGGGCG-30. To ensure equal loading of
Cell Stem Cell
Kinetics of Direct Mouse Somatic Cell ReprogrammingcDNA into RT reactions, GAPDH mRNA was amplified using the following:
F, 50-TTCACCACCATGGAGAAGGC-30; andR, 50-CCCTTTTGGCTCCACCCT-30.
Data were extracted from the linear range of amplification. All graphs of
qRT-PCR data shown represent samples of RNA that were DNase treated, re-
verse transcribed, and amplified in parallel to avoid variation inherent in these
procedures.
Supplemental Data
Supplemental Data include four figures and can be foundwith this article online
at http://www.cellstemcell.com/cgi/content/full/2/2/151/DC1/.
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